AVITA Medical, Inc. is a therapeutic acute wound care company. The Companyâs technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patientâs own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
äŒæ¥ã³ãŒãRCEL
äŒç€ŸåAVITA Medical Inc
äžå Žæ¥Mar 18, 2012
æé«çµå¶è²¬ä»»è
ãCEOãVance (Cary G)
åŸæ¥å¡æ°260
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Mar 18
æ¬ç€Ÿæåšå°28159 Avenue Stanford
éœåžVALENCIA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·91355
é»è©±çªå·16613679170
ãŠã§ããµã€ãhttps://www.avitamedical.com/
äŒæ¥ã³ãŒãRCEL
äžå Žæ¥Mar 18, 2012
æé«çµå¶è²¬ä»»è
ãCEOãVance (Cary G)